Bayzed Health Group Inc (02609) Releases Monthly Return for January 2026

Bulletin Express02-03 11:43

Bayzed Health Group Inc (02609) reported that its authorized share capital remained at 5,000,000,000 ordinary shares, each with a par value of US$0.00001, totaling US$50,000 as of January 31, 2026. The number of issued shares stood at 1,318,466,823, reflecting no change from the previous month.

No treasury shares were recorded, and no additional share issuance or share repurchase transactions took place. The company confirmed compliance with applicable public float requirements. No exercise of share options or convertible securities occurred during the reporting period, and no new agreements or arrangements were noted for the issue of additional shares.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment